To determine whether the observed dopaminergic axon protection in the striatum of Wld s mice is depenResults and Discussion dent on the site of 6-OHDA injection, a second experiment was performed by injecting the toxin in the right Parkinson disease (PD) is a common neurodegenerative midstriatum. Twelve days following 6-OHDA injections disorder characterized by the progressive loss of dopaat the level of dopaminergic nerve terminals, as opposed minergic neurons in the substantia nigra pars compacta.
the development of protective and restorative treatpamine will be rapidly released within the synaptic cleft via reverse action of the DAT transporter [19, 20] . In the ments for the whole neuronal function. For instance, a synergistic effect was obtained using a combination of intact side, most of the dopamine is sequestrated within presynaptic vesicles and thus has to be translocated to X chromosome-linked inhibitor of apoptosis (XIAP) and GDNF, rescuing both dopaminergic neurons and their the cytoplasm, however, at a slower limiting rate, before being released [21] . This abnormal storage of dopamine terminals [17] . 
